Cizzle Bio Launches CIZ1B Biomarker Blood Test for Early Lung Cancer

Now Available to Health Care Providers in Dallas-Fort Worth and San Antonio DALLAS, July 22, 2026 /PRNewswire/ -- Texas-based Cizzle Bio, Inc., a biotechnology company advancing biomarker blood tests for early lung and gastric cancers, today announced the commercial launch of its...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.